• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012 Product Image

Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012

  • Published: July 2012
  • Region: China
  • 60 Pages
  • China Research & Intelligence

Chemosynthetic polypeptide drugs are drugs combining the certain amino acids in chemical methods, which are characterized by favorable curable effects, few side-effects, high specificities and other advantages.

In the pharmaceutical industry, chemosynthetic polypeptides are the focus of attentions. On one hand, the indications of polypeptide drugs are in wide range and the curative effects are obvious, mainly for the application of tumor, metabolism, cardiovascular diseases, infectious diseases, etc. On the other hand, the development-success ratio of polypeptide drugs is high compared to that of traditional drugs and the approval ratio is also obviously higher than that of micromolecule chemical drugs. According to historical data, the approval ratio of polypeptide drugs in clinical research is 23 % to 26 %. As the rapid development of biochemical technologies and generic engineering field, polypeptide drugs are likely to replace the existing medicines.

By the end of 2011, there were 68 polypeptide drugs approved to the market (at least to sell in one country)globally, among which there were 51 treatment drugs mainly used in 14 cure fields, i.e., tumors, immunoregulation, READ MORE >

1 Basic Concept of Chemosynthetic Polypeptide Drugs
1.1 Definition
1.2 Classification
1.3 Advantages
1.3.1 Advantages over Micromolecule Drugs
1.3.2 Advantages over Protein Drugs
1.4 Industrial Policies
1.4.1 Industrial Administrative Departments
1.4.2 Link of Enterprise Establishment
1.4.3 Link of R&D of New Drugs
1.4.4 Drug Production

2 Global Chemosynthetic Polypeptide Drug Industry
2.1 Overview
2.1.1 Development Course
2.1.2 Competition Pattern
2.1.3 Market Scale
2.2 Major Polypeptide Drugs in Developed Countries
2.2.1 Copaxone
2.2.2 Lupron/Leuplin/Enantone
2.2.3 Zoladex
2.2.4 Sandostatin

3 Production of China's Chemosynthetic Polypeptide Drug Industry, 2011-2012
3.1 Development Course
3.2 Barriers to Entry
3.2.1 Technological Barrier
3.2.2 Capital Barrier
3.2.3 Policy Barrier
3.2.4 Market Barrier
3.3 Supply
3.3.1 Approved Chemosynthetic Polypeptide Drugs in China's Market
3.3.2 Major Manufacturers of Chemosynthetic Polypeptide Drugs in China

4 Demand of China's Chemosynthetic Polypeptide Drugs, 2011-2012
4.1 Consumption
4.1.1 Overview
4.1.2 Thymalfasin Consumption
4.1.3 Thymopentin Consumption
4.1.4 Somatostatin Consumption
4.1.5 Octreotide Consumption
4.1.6 Thyrocalcitonin Consumption
4.1.7 Consumption of Other Chemosynthetic Polypeptide Drugs
4.2 Current Market of China's Chemosynthetic Polypeptide Drugs, 2011
4.2.1 Overall Market
4.2.2 Thymalfasin
4.2.3 Thymopentin
4.2.4 Somatostatin
4.2.5 Octreotide
4.2.6 Thyrocalcitonin
4.2.7 Other Chemosynthetic Polypeptide Drugs

5 Top 8 Enterprises of China's Chemosynthetic Polypeptide Drug Industry, 2011-2012
5.1 Beijing Novartis Pharma Co., Ltd.
5.2 Shenzhen Hybio Pharmaceutical Co., Ltd.
5.3 Saisheng Pharmaceutical Co., Ltd.
5.4 Beijing Shiqiao Biochemical Pharmaceutical Co., Ltd.
5.5 Hainan Zhonghe Pharmaceutical Co., Ltd.
5.6 Merck Serono Co., Ltd.
5.7 Chengdu DIAO Jiuhong Pharmaceutical Factory
5.8 Hainan Shuangcheng Pharmaceutical Co., Ltd.

6 Prediction on Development of China's Chemosynthetic Polypeptide Drug Industry, 2012-2016
6.1 Development Trend of the Industry
6.2 Supply Prediction
6.3 Consumption Prediction
6.3.1 Overall Situation
6.3.2 Thymalfasin
6.3.3 Thymopentin
6.3.4 Somatostatin
6.3.5 Octreotide
6.3.6 Thyrocalcitonin
6.3.7 Other Chemosynthetic Polypeptide Drugs
6.4 Prediction on Market Scale
6.4.1 Thymalfasin
6.4.2 Thymopentin
6.4.3 Somatostatin
6.4.4 Octreotide
6.4.5 Thyrocalcitonin
6.5 Prediction on Market Competition
6.5.1 Prediction on Hot Products
6.5.2 Prediction on Competition Pattern

Selected Charts

Chart Comparison of Main Attributes in Chemosynthetic Polypeptide Drugs with Micromolecule Drugs and Protein Drugs
Chart Market Scale of China's Chemosynthetic Polypeptide Drugs, 2007-2011
Chart Consumption of China's Chemosynthetic Polypeptide Drugs, 2007-2011
Chart Proportion of Top 5 China's Chemosynthetic Polypeptide Drugs in Entire Market, 2007-2011
Chart China's Oxytocin Consumption, 2007-2011
Chart Approved Chemosynthetic Polypeptide Drugs in China's Market, 2012
Chart China's Major Manufacturers of Chemosynthetic Polypeptide Drugs
Chart Consumption of China's Chemosynthetic Polypeptide Drugs, 2007-2011
Chart China's Thymalfasin Consumption, 2007-2011
Chart China's Thymopentin Consumption, 2007-2011
Chart Market Scale of China's Major Chemical Synthesis Polypeptide Drug Varieties, 2011
Chart Market Scale of China's Thymalfasin, 2007-2011
Chart Market Share of China's Major Thymalfasin Manufacturers, 2009-2011
Chart Market Scale of China's Thymopentin, 2007-2011
Chart Sales Volume Share of Chemosynthetic Polypeptide Drugs of Beijing Novartis Pharma Co., Ltd., 2009-2011
Chart Major Products of Shenzhen Hybio Pharmaceutical Co., Ltd.
Chart Market Share of Thymalfasin of Saisheng Pharmaceutical Co., Ltd., 2009-2011
Chart Major Products of Hainan Zhonghe Pharmaceutical Co., Ltd.
Chart Major Products of Merck Serono Co., Ltd. in China
Chart Patent Situation of Global Important Polypeptide Drugs in China
Chart Prediction on Consumption of China's Chemosynthetic Polypeptide Drugs, 2012-2016
Chart Prediction on China's Thymalfasin Consumption, 2012-2016
Chart Prediction on Market Scale of China's Chemosynthetic Polypeptide Drugs, 2012-2016

- Beijing Novartis Pharma Co., Ltd.
- Shenzhen Hybio Pharmaceutical Co., Ltd.
- Saisheng Pharmaceutical Co., Ltd.
- Beijing Shiqiao Biochemical Pharmaceutical Co., Ltd.
- Hainan Zhonghe Pharmaceutical Co., Ltd.
- Merck Serono Co., Ltd.
- Chengdu DIAO Jiuhong Pharmaceutical Factory
- Hainan Shuangcheng Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos